TY  - GEN
AU  - Ishikawa,Toru
AU  - Imai,Michitaka
AU  - Kamimura,Hiroteru
AU  - Tsuchiya,Atsunori
AU  - Togashi,Tadayuki
AU  - Watanabe,Kouji
AU  - Seki,Kei-ichi
AU  - Ohta,Hironobu
AU  - Yoshida,Toshiaki
AU  - Kamimura,Tomoteru
TI  - Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study
SN  - 1007-9327
PY  - 2007///1220
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Hepatocellular
KW  - complications
KW  - Chemotherapy, Cancer, Regional Perfusion
KW  - Epirubicin
KW  - Etoposide
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Infusions, Intra-Arterial
KW  - Kaplan-Meier Estimate
KW  - Liver Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Pilot Projects
KW  - Portal Vein
KW  - pathology
KW  - Prospective Studies
KW  - Severity of Illness Index
KW  - Tablets, Enteric-Coated
KW  - Tegafur
KW  - Time Factors
KW  - Treatment Outcome
KW  - Uracil
KW  - Venous Thrombosis
KW  - drug therapy
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.3748/wjg.v13.i41.5465
ER  -